Pricing Log in Create free account

Acrivon Therapeutics, Inc. (ACRV) vs Coya Therapeutics, Inc. (COYA)

Acrivon Therapeutics, Inc. and Coya Therapeutics, Inc. are both Biotechnology companies. Acrivon Therapeutics, Inc. and Coya Therapeutics, Inc. are of similar size ($74.6M and $72.3M). Acrivon Therapeutics, Inc. has the higher net margin (0.00% vs −270.2%) and the higher return on invested capital (0.00% vs −15,230.9%). Across the 13 metrics below, Acrivon Therapeutics, Inc. leads on 7 and Coya Therapeutics, Inc. on 6.

Valuation

Metric ACRV COYA Biotechnology median
P/E n/m n/m 10.26
P/S n/m 8.25 9.18
P/B 0.76 1.53 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.31 n/m 0.65
EV/Sales n/m 4.48 8.98
Earnings yield (118.99%) (37.94%) (34.89%)
Free cash flow yield (97.02%) (26.87%) (24.52%)

Profitability

Metric ACRV COYA Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (288.70%) 0.00%
Net margin 0.00% (270.22%) 0.00%
Free cash flow margin 0.00% (221.64%) 0.00%
Return on equity (64.63%) (60.54%) (50.12%)
Return on assets (57.61%) (53.66%) (45.60%)
Return on invested capital 0.00% (15,230.92%) 0.00%

Growth

Metric ACRV COYA Biotechnology median
Revenue growth (TTM) — 108.35% 6.26%
EPS growth (last fiscal year) 15.13% (29.59%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACRV COYA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.99 13.40 4.89
Net debt to EBITDA 1.43 2.08 1.01

Dividend

Metric ACRV COYA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACRV COYA Biotechnology median
Market cap 74.57m 72.25m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack